Latest News and Press Releases

Rapid expansion in clinical applications, rising demand for genomic diagnostics, and increased investment in CRISPR-based therapeutics are fueling demand.

Lille (France), Cambridge (Massachusetts, États-Unis), Zurich (Suisse), le 07 avril 2026 – GENFIT (Euronext: GNFT), société biopharmaceutique engagée dans l’amélioration de la vie des patients...

Lille (France), Cambridge (Massachusetts, United States), Zurich (Switzerland), April 07, 2026 - GENFIT (Euronext: GNFT), a biopharmaceutical company dedicated to improving the lives of patients with...

New class action for Medpace (MEDP) urges investors to seek recovery for alleged securities fraud violations – lead plaintiff deadline of 6/5/2026

New York, USA, April 07, 2026 (GLOBE NEWSWIRE) -- Severe Asthma Clinical Trial Pipeline Appears Robust With 30+ Key Pharma Companies Actively Working in the Therapeutics Segment | DelveInsight |...

Madeira, Portugal, April 07, 2026 (GLOBE NEWSWIRE) -- European factories invest heavily in sensors, dashboards, and monitoring systems. Most of them know quickly when something goes wrong. But...

Louvain-la-Neuve, Belgium, April 7th, 2026 – 6 PM CET – In accordance with article 8:4 of the Royal Decree of 29 April 2019 executing the Belgian Code on Companies and Associations, Ion Beam...

New class action for Gartner, Inc. (IT) urges investors to seek recovery for alleged securities fraud violations – lead plaintiff deadline of 5/18/2026.

New class action for Pinterest, Inc. (PINS) urges investors to seek recovery for alleged securities fraud violations – lead plaintiff deadline of 5/29/2026

New class action for Corcept (CORT) urges investors to seek recovery for alleged securities fraud violations – lead plaintiff deadline of 4/21/2026